Qardio

Qardio manufactures clinically validated, AI-powered digital health devices for remote patient monitoring, including the QardioArm 2 wireless blood pressure monitor with irregular heartbeat detection, QardioBase X 12-metric smart body composition scale, QardioSpO2 pulse oximeter, and QardioTemp 2 digital forehead thermometer. The Qardio app integrates with Apple HealthKit and Google Play, enabling users to track vitals, share data with doctors, and manage hypertension, weight, and other health metrics. For healthcare professionals, Qardio provides end-to-end virtual care solutions including remote patient monitoring, cardiac rehabilitation, and chronic care management through its device-agnostic QardioMD platform. With over 12 years in business, billions of measurements worldwide, and only 1% accuracy deviation, Qardio is HSA and FSA eligible and ships globally. The platform is integrated with the American Heart Association for heart health management. Founded in 2012 and headquartered in San Francisco, United States, the company has raised approximately $29.1 million at the Series B stage.